Cardinal Health, Inc. $CAH Stake Reduced by Bokf Na

Key Points

• Bokf Na reduced its stake: Bokf Na cut holdings in Cardinal Health (NYSE:CAH) by 8.0%, selling 11,025 shares to finish the quarter with 126,183 shares worth about $25.93 million, and institutional investors now own roughly 87.17% of the company.
• Quarterly results and guidance: Cardinal Health beat EPS expectations with $3.17 (vs. $2.79 est.) but missed revenue at $60.94 billion (vs. $62.10B est.), and issued FY2026 guidance of $10.70–$10.80 in EPS.
• Analyst consensus and stock metrics: Analysts rate CAH a "Moderate Buy" with an average target of $241.80 (targets range about $215–$275), while the stock trades near $197, has a ~30x PE, and the company raised its quarterly dividend to $0.5158 (≈1.0% yield).

Bokf Na cut its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 8.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 126,183 shares of the company's stock after selling 11,025 shares during the quarter. Bokf Na owned about 0.05% of Cardinal Health worth $25,931,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Aventura Private Wealth LLC purchased a new position in Cardinal Health in the 4th quarter worth about $25,000. Jones Financial Companies Lllp increased its stake in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock worth $27,000 after purchasing an additional 14,034 shares in the last quarter. JPL Wealth Management LLC purchased a new position in Cardinal Health in the 3rd quarter worth about $31,000. Turning Point Benefit Group Inc. purchased a new position in Cardinal Health in the 3rd quarter worth about $31,000. Finally, American Capital Advisory LLC increased its stake in Cardinal Health by 5,200.0% in the 3rd quarter. American Capital Advisory LLC now owns 212 shares of the company's stock worth $33,000 after purchasing an additional 208 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company's stock.

Analysts Set New Price Targets

CAH has been the topic of a number of analyst reports. Robert W. Baird set a $248.00 price target on Cardinal Health in a research note on Friday. JPMorgan Chase & Co. dropped their price target on Cardinal Health from $243.00 to $215.00 and set a "neutral" rating on the stock in a research note on Monday. Barclays lifted their price target on Cardinal Health from $243.00 to $258.00 and gave the stock an "overweight" rating in a research note on Tuesday, February 24th. Leerink Partners reissued an "outperform" rating and issued a $275.00 price target on shares of Cardinal Health in a research note on Monday, March 9th. Finally, William Blair initiated coverage on Cardinal Health in a research note on Tuesday, April 28th. They issued an "outperform" rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $241.80.

Cardinal Health Price Performance

NYSE:CAH opened at $196.97 on Wednesday. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $233.60. The stock's 50-day moving average is $213.19 and its two-hundred day moving average is $206.47. The stock has a market cap of $46.13 billion, a PE ratio of 30.12, a price-to-earnings-growth ratio of 1.17 and a beta of 0.53.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company had revenue of $60.94 billion for the quarter, compared to analysts' expectations of $62.10 billion. During the same quarter in the previous year, the business posted $2.35 EPS. The business's revenue for the quarter was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. This is a boost from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 1.0%. Cardinal Health's dividend payout ratio (DPR) is presently 31.19%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.